Disulfiram: A Proven Pharmacological Deterrent for Alcohol Dependence
| Product dosage: 60mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.38 | $41.31 (0%) | 🛒 Add to cart |
| 60 | $1.11 | $82.62 $66.50 (20%) | 🛒 Add to cart |
| 90 | $1.02 | $123.93 $91.68 (26%) | 🛒 Add to cart |
| 120 | $0.98 | $165.23 $117.88 (29%) | 🛒 Add to cart |
| 180 | $0.94 | $247.85 $169.26 (32%) | 🛒 Add to cart |
| 270 | $0.91 | $371.78 $244.83 (34%) | 🛒 Add to cart |
| 360 | $0.89
Best per pill | $495.70 $319.38 (36%) | 🛒 Add to cart |
Synonyms | |||
Disulfiram is an aversive pharmacological agent approved for use in the management of chronic alcohol use disorder. It functions as a deterrent by producing a highly unpleasant physiological reaction upon the ingestion of ethanol, thereby supporting abstinence as part of a comprehensive treatment plan that includes counseling and psychosocial support. Its efficacy is predicated on a well-understood biochemical mechanism, making it a cornerstone of medical management for motivated patients committed to sobriety.
Features
- Active Pharmaceutical Ingredient: Disulfiram.
- Mechanism of Action: Irreversible inhibition of the enzyme aldehyde dehydrogenase (ALDH).
- Administration: Oral tablet, typically 250mg or 500mg.
- Treatment Context: For use as part of a supervised, comprehensive treatment program.
- Onset of Action: The disulfiram-ethanol reaction (DER) can occur within 10 minutes of alcohol ingestion and may persist for an hour or more.
- Duration of Effect: The enzymatic inhibition can persist for up to 14 days after the last dose due to the irreversible nature of the binding.
Benefits
- Creates a powerful psychological and physical deterrent to alcohol consumption, reinforcing commitment to abstinence.
- Provides a tangible pharmacological tool that empowers patients within a structured recovery program.
- Helps break the cycle of compulsive drinking by introducing a immediate, negative consequence for alcohol use.
- Can reduce alcohol cravings in some patients by mitigating the preoccupation with drinking due to the fear of the reaction.
- Supports long-term sobriety goals when combined with behavioral therapies and peer support networks.
- Offers a clear-cut mechanism that patients can understand, facilitating informed consent and engagement in their treatment.
Common use
Disulfiram is indicated as an adjunctive therapy in the management of selected patients with chronic alcohol use disorder who wish to remain in a state of enforced sobriety. It is most effective for highly motivated individuals in a stable mental and physical condition who are participating in a supervised treatment program. The patient must fully comprehend the consequences of alcohol consumption while on the medication and must voluntarily consent to therapy. It is not intended for use as a standalone treatment and is ineffective in patients who are actively intoxicated or without their knowledge.
Dosage and direction
Initial Dosing: The initial dosage must be administered only when the patient has abstained from alcohol for at least 12 hours. A maximum dose of 500 mg daily is given orally as a single dose for the first one to two weeks. Maintenance Dosing: The average maintenance dose is 250 mg daily (range 125 mg to 500 mg). Dosage should be tailored to the individual’s tolerance and the effectiveness of the deterrent response. Administration: The tablet can be crushed and mixed with liquid if necessary. It is best taken in the morning, as the sedative effects, if they occur, may be less disruptive. Duration of Therapy: The duration of treatment is indefinite and must be determined on a case-by-case basis, continuing as long as the patient is deemed to benefit from the deterrent effect. The decision to discontinue should be made collaboratively with the healthcare provider.
Precautions
- A thorough physical and psychiatric examination should precede prescription. Liver function tests (LFTs) and a complete blood count (CBC) are mandatory at baseline and at regular intervals (e.g., every 3-6 months) during therapy due to the risk of hepatotoxicity.
- Patients must be explicitly warned that the disulfiram-ethanol reaction can occur with any form of alcohol, including that found in sauces, vinegars, mouthwashes, elixirs, tonics, and even topical preparations like aftershave or hand sanitizer, which can be absorbed through the skin or inhaled.
- Use with extreme caution in patients with diabetes mellitus, hypothyroidism, epilepsy, cerebral damage, chronic or acute nephritis, hepatic disease or impairment, and cardiovascular disease.
- May cause drowsiness or dizziness. Patients should be cautioned about operating machinery or driving until they know how the medication affects them.
- Psychiatric status should be monitored, as disulfiram has been associated with the exacerbation of psychosis and the emergence of depression, paranoia, and other psychiatric symptoms.
- Patients should carry a medical identification card stating they are on disulfiram therapy to alert medical personnel in case of an emergency.
Contraindications
- Hypersensitivity to disulfiram or any other components of the formulation.
- Severe myocardial disease or coronary occlusion.
- Psychosis.
- Patients who are receiving or have recently received metronidazole, paraldehyde, or alcohol-containing products.
- Pregnancy, unless the potential benefit justifies the potential risk to the fetus.
Possible side effect
Common:
- Drowsiness, fatigue, headache, metallic or garlic-like aftertaste.
- Acneiform eruptions, allergic dermatitis. Less Common but Serious:
- Hepatotoxicity: Can range from transient transaminase elevations to fulminant hepatitis and hepatic failure. Symptoms include fatigue, weakness, anorexia, nausea, vomiting, jaundice, and dark urine.
- Peripheral neuropathy: Including paresthesia, weakness, and pain in the extremities.
- Optic neuritis: Blurred vision and changes in visual acuity.
- Psychiatric effects: Depression, paranoia, manic episodes, psychosis, confusion.
- Polyneuritis.
Drug interaction
Disulfiram inhibits several hepatic microsomal enzymes, notably those of the CYP450 2E1 and 2C9 families, leading to numerous potential interactions:
- Warfarin: Disulfiram potentiates the anticoagulant effect by inhibiting its metabolism, increasing the risk of bleeding. Prothrombin time must be monitored closely, and warfarin dosage will likely need reduction.
- Phenytoin: Disulfiram inhibits the metabolism of phenytoin, significantly increasing its serum levels and risk of toxicity (ataxia, nystagmus, lethargy). Phenytoin levels must be monitored.
- Benzodiazepines (e.g., diazepam, chlordiazepoxide): Metabolism may be inhibited, potentiating sedative effects.
- Theophylline: Disulfiram may decrease theophylline clearance, increasing the risk of toxicity.
- Tricyclic Antidepressants: Metabolism may be inhibited.
- Isoniazid: Concurrent use may increase the risk of central nervous system side effects, such as dizziness and unsteadiness.
- Metronidazole: Concomitant use may induce confusion and psychotic reactions; it is contraindicated.
Missed dose
If a dose is missed, it should be taken as soon as remembered on that same day. If it is not remembered until the next day, the missed dose should be skipped, and the regular dosing schedule resumed. The patient should not take a double dose to make up for the missed one. Consistency is key to maintaining enzymatic inhibition.
Overdose
Symptoms: Overdose is an extension of its pharmacological effects and adverse reactions. Symptoms may include severe nausea, vomiting, dizziness, lethargy, incoordination, seizures, and cardiovascular collapse. In the absence of alcohol, neurological symptoms like extrapyramidal reactions and acute psychosis may dominate. Management: There is no specific antidote for disulfiram overdose. Management is entirely supportive and symptomatic. Gastric lavage may be considered if ingestion was recent. Support of respirations and cardiovascular system is paramount. In cases of severe hypotension, intravenous fluids and vasopressors may be required. The patient must be protected from any exposure to alcohol or alcohol-containing products for at least two weeks.
Storage
Store at controlled room temperature, 20°C to 25°C (68°F to 77°F). Dispense in a tight, light-resistant container as defined in the USP. Keep out of reach of children and pets. Do not flush medications down the toilet or pour them into a drain unless instructed to do so.
Disclaimer
This information is for educational and informational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read here. The author and publisher are not responsible for any specific health or allergy needs that may require medical supervision and are not liable for any damages or negative consequences from any treatment, action, application, or preparation, to any person reading or following the information in this document.
Reviews
“Disulfiram was the necessary tool that provided the tangible consequence my patient needed to break his cycle of relapse. Within our structured outpatient program, it empowered him to say no, knowing the reaction was a certainty. Monitoring his LFTs was crucial, but the benefit far outweighed the management required.” – Addiction Psychiatrist, MA “For the motivated patient, it’s a game-changer. It’s not a magic pill, but it buys them time—time away from alcohol where they can engage effectively in therapy and rebuild their life. The key is patient education; they must fully understand and consent to the ‘deal’ they are making with this medication.” – Certified Addiction Registered Nurse, CA “I’ve prescribed disulfiram for over two decades. Its effectiveness is 100% dependent on patient commitment. In those who are truly ready, it’s remarkably effective. However, it demands rigorous clinical vigilance, particularly regarding liver function and potential drug interactions.” – Internal Medicine Physician, TX